NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters
In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact
NCAB Approves CCP, Agrees To Compromise On Including Control
$5 Million Lift Raises Payline From 180 to 185
DRCCA Board Cool On communications Network, Hears Report On Behavior Program
HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials
Program Announcement In Preventative Oncology
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









